Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

CLL Society Emphasizing Critical Need to Carefully Implement New Medicare Part D “Patient Cap” and “Smoothing” Changes Enacted Late 2022

In science and medicine, information is constantly changing and may become out-of-date as new data emerge. All articles and interviews are informational only, should never be considered medical advice, and should never be acted on without review with your health care team.

Congress passed a law in late 2022 addressing two key issues for patients insured through Medicare Part D. The law creates an annual $2,000 cap on patient out of pocket costs and it sets up a so-called “smoothing” process so that the costs are not incurred all in one month. Rather they can be “smoothed” or spread across the year.

While this promises to be a huge improvement for patients, we need to ensure this will be implemented clearly and simply for patients, and not be administered in a way to deny patients care under Part D.

CLL Society joined other advocates to raise awareness of the need to implement the new out-of-pocket cap and ‘smoothing’ provisions in patient friendly and approachable way as possible.

Note: Medicare eligibility is either by age (age 65+) or disability, and Part D is for generally for coverage of oral or self-injected medications.

Download the letter here.